EP 3493814 A4 20200722 - LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION
Title (en)
LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION
Title (de)
LIPID-SUBSTITUIERTE AMINO-1,2- UND 1,3-DIOLVERBINDUNGEN ALS MODULATOREN DER TLR2-DIMERISIERUNG
Title (fr)
COMPOSÉS AMINO 1,2-ET 1,3-DIOL SUBSTITUÉS PAR DES LIPIDES EN TANT QUE MODULATEURS DE LA DIMÉRISATION DE TLR2
Publication
Application
Priority
- US 201662370637 P 20160803
- US 2017044984 W 20170801
Abstract (en)
[origin: WO2018026866A1] The present invention relates to lipid-substituted amino 1,2- and 1,3-diol compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.
IPC 8 full level
A61K 31/66 (2006.01); C07C 217/18 (2006.01); C07C 237/08 (2006.01); C07C 237/20 (2006.01); C07C 271/24 (2006.01); C07C 279/14 (2006.01); C07C 311/19 (2006.01); C07D 207/16 (2006.01); C07D 209/14 (2006.01); C07F 9/02 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 9/00 (2017.12); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/04 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/06 (2017.12); A61P 21/00 (2017.12); A61P 25/00 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 31/14 (2017.12); A61P 31/20 (2017.12); A61P 31/22 (2017.12); A61P 35/00 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07C 217/18 (2013.01); C07C 237/08 (2013.01); C07C 237/20 (2013.01); C07C 237/24 (2013.01); C07C 271/22 (2013.01); C07C 271/24 (2013.01); C07C 279/14 (2013.01); C07C 279/24 (2013.01); C07C 311/19 (2013.01); C07C 311/64 (2013.01); C07D 207/16 (2013.01); C07D 209/14 (2013.01); C07D 209/18 (2013.01); C07D 209/20 (2013.01); C07D 209/26 (2013.01); C07D 209/42 (2013.01); C07D 211/34 (2013.01); C07D 211/62 (2013.01); C07D 211/64 (2013.01); C07D 211/66 (2013.01); C07D 233/64 (2013.01); C07D 295/155 (2013.01); C07D 295/205 (2013.01); C07C 2601/14 (2017.04); C07C 2603/18 (2017.04)
Citation (search report)
- [I] WO 02072068 A2 20020919 - CANCER RES CAMPAIGN TECH [GB], et al
- [AD] WO 2013135360 A1 20130919 - MERCK PATENT GMBH [DE]
- [A] EP 0451763 A2 19911016 - FUJI PHOTO FILM CO LTD [JP]
- See references of WO 2018026866A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2018026866 A1 20180208; CN 109715167 A 20190503; EP 3493814 A1 20190612; EP 3493814 A4 20200722; JP 2019524781 A 20190905
DOCDB simple family (application)
US 2017044984 W 20170801; CN 201780048372 A 20170801; EP 17837574 A 20170801; JP 2019505479 A 20170801